Cost-effectiveness of Ivabradine as a Treatment for Systolic Chronic Heart Failure in the United States

被引：0
|
作者：
Kansal, Anuraag R.
Cowie, Martin
Kielhorn, Adrian
Krotneva, Stanimira
Taffazzoli, Ali
Zheng, Ying
Yurgin, Nicole
机构：
来源：
CIRCULATION | 2015年 / 132卷
关键词：
cost effectiveness; systolic chronic heart failure; ivabradine; quality-adjusted life years; hospitalization;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
17655
引用
下载
收藏
页数：4
相关论文
共 50 条
  • [11] THE COST-EFFECTIVENESS OF TREATMENT FOR CHRONIC HEART FAILURE: A SYSTEMATIC REVIEW
    Webb, N.
    Cowie, M. R.
    Taylor, M.
    Briggs, A.
    Cohen, A.
    de Pouvourville, G.
    Haroun, R.
    Trueman, D.
    Deschaseaux, C.
    VALUE IN HEALTH, 2015, 18 (07) : A391 - A391
  • [12] Budget Impact of Adding Ivabradine to Standard of Care in Patients with Chronic Systolic Heart Failure in the United States
    Borer, Jeffrey S.
    Kansal, Anuraag R.
    Dorman, Emily D.
    Krotneva, Stanimira
    Zheng, Ying
    Patel, Harshali K.
    Tavazzi, Luigi
    Komajda, Michel
    Ford, Ian
    Boehm, Michael
    Kielhorn, Adrian
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2016, 22 (09): : 1064 - 1071
  • [13] Cost-Effectiveness Analysis of the Adjunctive Therapy of Ivabradine for the Treatment of Heart Failure with Reduced Ejection Fraction
    Krittayaphong, Rungroj
    Yadee, Jirawit
    Permsuwan, Unchalee
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2019, 11 : 767 - 777
  • [14] COST EFFECTIVENESS AND COST UTILITY ANALYSES OF IVABRADINE (PROCORALAN®) IN THE TREATMENT OF PATIENTS WITH CHRONIC HEART FAILURE IN MEXICO
    Soto, H.
    Pizarro, M.
    Botello, B. S.
    Almeida, E.
    VALUE IN HEALTH, 2013, 16 (03) : A286 - A286
  • [15] Cost-Effectiveness Analysis of Sacubitril/Valsartan for the Treatment of Heart Failure with Reduced Ejection Fraction in the United States
    Zueger, Patrick M.
    Kumar, Varun M.
    Harrington, Rachel L.
    Rigoni, Gianna C.
    Atwood, Alicia
    DiDomenico, Robert J.
    Touchette, Daniel R.
    PHARMACOTHERAPY, 2018, 38 (05): : 520 - 530
  • [16] Cost-effectiveness analysis of carvedilol for the treatment of chronic heart failure in Japan
    Inomata, T
    Izumi, T
    Kobayashi, M
    CIRCULATION JOURNAL, 2004, 68 (01) : 35 - 40
  • [17] Cost-Effectiveness Analysis of Empagliflozin for Treatment of Patients With Heart Failure With Reduced Ejection Fraction in the United States
    Reifsnider, Odette S.
    Tafazzoli, Ali
    Linden, Stephan
    Ishak, Jack
    Rakonczai, Pal
    Stargardter, Matthew
    Kuti, Effie
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (04):
  • [18] Ivabradine is cost-effective in the treatment of chronic heart failure
    Morris, Stephen
    Hunter, Rachael
    HEART, 2014, 100 (13) : 991 - 992
  • [19] Ivabradine in Heart Failure The Representativeness of SHIFT (Systolic Heart Failure Treatment With the IF Inhibitor Ivabradine Trial) in a Broad Population of Patients With Chronic Heart Failure
    Das, Debraj
    Savarese, Gianluigi
    Dahlstrom, Ulf
    Fu, Michael
    Howlett, Jonathan
    Ezekowitz, Justin A.
    Lund, Lars H.
    CIRCULATION-HEART FAILURE, 2017, 10 (09)
  • [20] Cost-effectiveness of implantable cardiac devices in patients with systolic heart failure
    Mealing, Stuart
    Woods, Beth
    Hawkins, Neil
    Cowie, Martin R.
    Plummer, Christopher J.
    Abraham, William T.
    Beshai, John F.
    Klein, Helmut
    Sculpher, Mark
    HEART, 2016, 102 (21) : 1742 - 1749
12345